Cochlear celebrates 30 Years in China and the launch of the world’s first and only smart hearing implant system
The new Cochlear™ Nucleus® Nexa™ System is the first and only hearing implant featuring internal memory and upgradeable firmware.1+ This year marks the 30-year anniversary since the first adult cochlear implant surgery in mainland China which took place in 1995. Nearly 10 million people in China are suffering from severe to profound hearing loss, among whom only 1% are...
Ottai Unveils Revolutionary AI-Powered Biosensor Set to Transform Chronic Disease Care
Groundbreaking Technology Empowers Patients to Take Control of Their Health HONG KONG, June 20, 2025 /PRNewswire/ -- Ottai, an Oxford-originated pioneer in AI digital health innovation, today announced the launch of its next-generation AI-powered wearable designed to revolutionize chronic disease management. This breakthrough device continuously monitors key biomarkers, leverages AI for real-time analysis and health log input,...
SURGLASSES Launches the World’s First AI Anatomy Table
Asclepius AI Table sets a new benchmark for intelligent, hands-on medical learning. TAIPEI, June 20, 2025 /PRNewswire/ -- Surglasses Inc. today announced the launch of the Asclepius AI Table, the world's first anatomy table with fully integrated AI instruction — a groundbreaking device that brings real-time intelligence and immersive interaction into medical and veterinary education. ...
Aussie Families Paying the Winter Flu Penalty: New Data Reveals the Costly Impact of Cold and Flu on Households
As Australian families grapple with rising living costs, new research reveals the toll of winter cold and flu on household finances, as well as family health and wellbeing. SYDNEY, June 20, 2025 /PRNewswire/ -- New research released reveals the majority (86%) of Aussie families are facing extra expenses each cold and flu season, with 42%...
Dizal Completes Enrollment for its Phase III Pivotal Study of Sunvozertinib vs. Platinum Doublet in Treatment Naïve NSCLC Patients with EGFR Exon20 Insertional Mutations
SHANGHAI, June 19, 2025 /PRNewswire/ -- Dizal announced the completion of patient enrollment for its WU-KONG28 clinical trial: a multinational, randomized phase III study evaluating the efficacy and safety of sunvozertinib versus platinum-based doublet chemotherapies as a first-line treatment for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations...
The Department of Health – Abu Dhabi and Sanofi Forge Strategic Alliance to Accelerate the Development of New Global Vaccines in Abu Dhabi
On the sidelines of a high-level US visit focused on healthcare innovation ABU DHABI, UAE, June 19, 2025 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has signed a Memorandum of Understanding (MoU) with Sanofi, a research and development-driven, AI-powered healthcare...
L’Oréal Showcases New Frontiers of Beauty Powered by North Asia Open Innovation at Viva Tech
SHANGHAI, June 19, 2025 /PRNewswire/ -- On June 12, L'Oréal showcased its fast-evolving North Asia open innovation ecosystem at Viva Technology in Paris, through a dedicated forum themed "New Frontiers of Beauty Powered by North Asia Open Innovation." The event brought together top startups from China, Japan, and South Korea — standout performers from the L'Oréal Big Bang Beauty...
111, Inc. Announces First Quarter 2025 Unaudited Financial Results
Maintained Quarterly Operational Profitability Operating Expenses as a Percentage of Revenues Decreased 30 Basis Points YoY Maintained Quarterly Positive Operating Cash Flow SHANGHAI, June 19, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream...
Immuno Cure and PharmaJet Announce Collaboration to Advance a Novel HIV Therapeutic DNA Vaccine Using Needle-Free Technology in Humans
HONG KONG, June 19, 2025 /PRNewswire/ -- Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboration with PharmaJet® to evaluate the safety and immunogenicity of HIV therapeutic DNA vaccine, ICVAX, delivered via PharmaJet's innovative Tropis® needle-free injection system in a clinical study. On June 16, 2025, Immuno...
MALAYSIA HIGHLIGHTS MEDICAL AND TOURISM SYNERGY AT THE MALAYSIA HEALTHCARE EXPO MAKASSAR 2025
Over 15 Malaysian hospitals and Tourism Selangor spotlight world-class care and vibrant recovery tourism for Indonesian patients, led by the Malaysia Healthcare Travel Council KUALA LUMPUR, Malaysia, June 19, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC), in collaboration with Tourism Selangor, is currently hosting the second edition of...
